Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression

Sponsor
Radboud University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00928980
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (Other)
317
13
3
49
24.4
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the (cost)effectiveness of mindfulness based cognitive therapy (MBCT) compared to that of antidepressant medication, and its combination with regard to the prevention of relapse or recurrence in patients with recurrent depression.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness Based Cognitive Therapy
  • Drug: Optimal Medical Care
N/A

Detailed Description

In the Netherlands, treatment as usual for patients with (recurrent) Major Depressive Disorder consists of maintenance antidepressant medication. Mindfulness-based cognitive therapy (MBCT) is a recently developed psychological intervention that appears to be promising in terms of preventing relapse or recurrence in patients with recurrent depression. It consists of 8 weekly group sessions in which meditation exercises are combined with cognitive therapeutic elements such as identifying negative thoughts and monitoring and scheduling activities.

In this study, the (cost)effectiveness of a) MBCT on its own, b) antidepressant medication on its own and c) the combination of MBCT and antidepressant medication will be investigated in 350 patients with recurrent depression who are currently in remission.

Study Design

Study Type:
Interventional
Actual Enrollment :
317 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Clinical and Cost-effectiveness of Mindfulness Based Cognitive Therapy, Maintenance Antidepressant Medication and Its Combination in the Prevention of Relapse in Patients With Recurrent Depression
Study Start Date :
May 1, 2009
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness Based Cognitive Therapy

Mindfulness Based Cognitive Therapy and withdrawal of antidepressant medication between the 4th and 5th session, patients being off medication until the end of study period (15 months).

Behavioral: Mindfulness Based Cognitive Therapy
Mindfulness Based Cognitive Therapy is an 8-week during group intervention encompassing meditation practice and cognitive therapy techniques.

Experimental: Combination

Mindfulness Based Cognitive Therapy combined with the use of antidepressant medication during the study (15 months).

Behavioral: Mindfulness Based Cognitive Therapy
Mindfulness Based Cognitive Therapy is an 8-week during group intervention encompassing meditation practice and cognitive therapy techniques.

Drug: Optimal Medical Care
Therapeutic dose of antidepressant medication

Active Comparator: Optimal Medical Care

Treatment with optimal medical care: therapeutic dose of antidepressant medication during at least 15 months, administered in accordance with current guidelines.

Drug: Optimal Medical Care
Therapeutic dose of antidepressant medication

Outcome Measures

Primary Outcome Measures

  1. Relapse/recurrence of Major Depressive Episode [3, 6, 9, 12, 15 months]

    Relapse or recurrence of depression will be assessed trimonthly using the Structured Clinical Interview for DSM-V (SCID) depression module.

Secondary Outcome Measures

  1. Costs made by consumption of medical care and production loss [3, 6, 9, 12, 15 months]

    Using prospective calendars and retrospective questionnaires about contacts with health care in the past 3 months (assessed trimonthly) we will estimate the costs of depression health care and the quality of life (selfreport). We will compare the cost-effectiveness ratios between the groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Recurrent Major Depressive Episode (at least 3 previous episodes)

  • Treatment with therapeutic dose of antidepressant medication during past six months

  • Currently in full or partial remission

Exclusion Criteria:
  • Bipolar disorder (current and previous (hypo)manic episodes)

  • Psychotic disorder (current and previous)

  • Neurological or somatic illness affecting depression or outcome measures

  • Current alcohol or drugs dependency

  • Use of high dosage benzodiazepines (> 2 mg Lorazepam equivalents daily)

  • Recent Electro Convulsive Therapy (< 3 months ago)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pro Persona Arnhem Gelderland Netherlands 6800
2 Pro Persona Ede Gelderland Netherlands
3 Radboud University Nijmegen Medical Center Nijmegen Gelderland Netherlands 6525 GC
4 Pro Persona Tiel Gelderland Netherlands
5 GGZ Noord-Holland-Noord Alkmaar Noord-Holland Netherlands
6 Free University Medical Center and GGZ In Geest Amsterdam Noord-Holland Netherlands 1000
7 AMC Amsterdam Amsterdam North Holland Netherlands 1100 DD
8 GGZ Centraal Amersfoort Utrecht Netherlands 3800
9 GGZ Rivierduinen - Leiden Leiden Zuid Holland Netherlands 2300 AT
10 Leiden University Medical Center Leiden Zuid Holland Netherlands 2300 RC
11 PsyQ Den Haag Zuid-Holland Netherlands 2500
12 Parnassia ACO Zuid Den Haag Zuid-Holland Netherlands
13 GGZ Duin- en Bollenstreek Katwijk Netherlands

Sponsors and Collaborators

  • Radboud University Medical Center
  • ZonMw: The Netherlands Organisation for Health Research and Development

Investigators

  • Principal Investigator: Anne EM Speckens, Prof. dr., Radboud University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Anne Speckens, Prof. dr. Anne E.M. Speckens, Radboud University Medical Center
ClinicalTrials.gov Identifier:
NCT00928980
Other Study ID Numbers:
  • MFN-2009-2013
  • 80-82310-98-09018
  • 2008/242
First Posted:
Jun 26, 2009
Last Update Posted:
Nov 13, 2020
Last Verified:
Nov 1, 2020
Keywords provided by Anne Speckens, Prof. dr. Anne E.M. Speckens, Radboud University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2020